Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RHOQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HPRT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSNAX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LAMP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARPP19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00574 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FAM76B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MICU3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724689 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBAK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCRLA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SECISBP2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SGTB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on